Brief: Cymabay Reports Second Quarter And Six Months Ended June 30, 2022 Financial Results And Provides Corporate Update
11/08/2022 22:14
Aug 11 (Reuters) - Cymabay Therapeutics Inc CBAY.O :
* CYMABAY REPORTS SECOND QUARTER AND SIX MONTHS ENDED JUNE
30,
2022 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
* QTRLY NET LOSS $0.31 PER SHARE
* Q3 EARNINGS PER SHARE VIEW $-0.31 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX4fZB7b
Further company coverage: CBAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CymaBay Therapeutics
See all newsBrief: CymaBay Says EMA Accepted For Review The Marketing Authorization Application For Seladelpar
U.S. RESEARCH ROUNDUP-Bruker Corp, Cymabay Therapeutics, SSR Mining
U.S. RESEARCH ROUNDUP-An2 Therapeutics, Par Technology, Trimble
U.S. STOCKS ON THE MOVE-Perpetua Resources, Nvidia, SiriusXM
U.S. STOCKS ON THE MOVE-Lowe's, Bit Digital Snap